Tamoxifen and metabolites in mcf? cells: Correlation between binding to estrogen receptor and inhibition of cell growth

Cancer Research

Volumn 42, Issue 1, 1982, Pages 317-323

  Coezy, Ericque ^a   Borgna, Jean Louis ^a   Rochefort, Henri ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ESTROGEN RECEPTOR; TAMOXIFEN; DRUG METABOLITE; DRUG RECEPTOR; RADIOISOTOPE;

ARTICLE; BIOTRANSFORMATION; BREAST TUMOR; CELL DIVISION; CELL LINE; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; STRUCTURE ACTIVITY RELATION; BREAST; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL GROWTH; ESTRADIOL H 3; HUMAN CELL; HYDROXYTAMOXIFEN H 3; IN VITRO STUDY; TAMOXIFEN H 3;

BIOTRANSFORMATION; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; FEMALE; HUMAN; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TAMOXIFEN;

EID: 0020003085     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Adam, H. K., Douglas, E. J., and Kemp. J. O. The metabolism of tamoxifen In humans. Biochem. Pharmacol., 27: 145-147, 1979.
2. Borgna. J. L., and Rochefort, H. Occupation in vivo des récepteurs oestro-gènes par des métabolites hydroxylés du tamoxiféne. C. R. Hebd. Seances Acad. Sci., 289: 1141-1144, 1979.
3. Borgna, J. L., and Rochefort, M. High affinity binding to the estrogen receptor of [3H]4-hydroxy tamoxifen, an active antiestrogen metabolite. Mol. Cell. Endocrinol., 20: 71–85, 1980.
4. Borgna, J. L., and Rochefort, H. Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. J. Biol. Chem., 256: 859–868, 1981.
5. Bouton, M. M., and Raynaud, J. P. The relevance of interaction kinetics in determining biological response to estrogens. Endocrinology, 105: 509–515, 1979.
6. Brooks, S. C., Locke, E. R., and Soule. H. D. Estrogen receptor in human cell line (MCF7) from breast carcinoma. J. Biol. Chem., 248: 6251–6253, 1973.
7. Capony, F., and Rochefort, H. In vivo effect of antiestrogens on the localisation and replenishment of estrogen receptor. Mol. Cell. Endocrinol., 3: 233–251, 1975.
8. Capony, F., and Rochefort, H. High affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor. Mol. Cell. Endocrinol. 11: 181-198, 1978.
9. Coezy, E., Borgna, J. L., and Rochefort, H. Relative efficiency of tamoxifen and OH-tamoxifen in two human breast cancer cell lines (MCF7 and ZR-75-1). International Study Group for Steroid Hormones. IXth Meeting. Rome. 1979.
10. Daniel, C. P., Gaskell, S. J., Bishop, H., and Nicholson, R. I. Determination of tamoxifen and an hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometry. J. Endocrinol., 63: 401-408, 1978.
11. Edwards. D. P., Adams. D. J., Savage, N., and McGuire, W. L. Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem. Biophys. Res. Commun., 93: 804–812, 1980.
12. Fromson. J. M., Pearson, S., and Brahma. S. The metabolism of tamoxifen in laboratory animals. Xenobiotica, 3: 693–709, 1973.
13. Furr, B. J., Patterson, J. S., Richardson, D. N., Slater, S. R., and Wakeling, A. L. In: M. E. Goldberg (ed.), Pharmacological and Biochemical Properties of Drugs Substances. Vol. 2, pp. 335–399. Washington, D.C.: American Pharmaceutical Association, 1979.
14. Harper, M. J. K., and Walpole. A. L. Contrasting endocrine activity of cis and trans isomers in a series of substituted triphenylethylene. Nature (Lond.), 212: 87, 1966.
15. Harper, M. J. K., and Walpole, A. L. A new derivative of triphenylethylene: effect on Implantation and mode of action in rats. J. Reprod. Fertil., 13: 101–119, 1967.
16. Horwitz, K. B., and McGuire, W. L. Estrogen control of progesterone receptor in human breast cancer. J. Biol. Chem., 253: 2223–2228, 1978.
17. Jordan, V. C., Collins, M. M., Rowsby, L., and Prestwich, G. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. J. Endocrinol., 75. 305–316, 1977.
18. Karsten, U., and Wollenberger, A. Improvements in the BET method for direct fluorometric estimation of DNA and RNA in cell and tissue homogenate. Anal. Biochem., 77. 464–470. 1977.
19. Korenman, S. G. Relation between estrogen inhibitory activity and binding to cytosol of rabbit and human uterus. Endocrinology. 87: 1119–1123.
20. Koseki, Y., Zava, D. T., Chamness, G. C., and McGuire, W. L. Estrogen receptor translocation and replenishment by the antiestrogen tamoxifen. Endocrinology, 101: 1104-1110, 1977.
21. Le Pecq, J. B., and Paoletti, C. A new fluorometric method for RNA and DNA determination. Anal. Biochem., 17: 100-107, 1966.
22. Uppman, M. E., Allegra, J. C., and Strobl, J. S. Growth requirements of a human breast cancer cell line in serum-free medium. Cold Spring Harbor Conf. Cell Proliferation, 6. 645–658, 1979.
23. Uppman, M. E., Bolan, G., and Huh, K. The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long-term tissue culture. Cancer Res., 36: 4595-4601, 1977.
24. Nicholson, R. I., Syne, J. S., Daniel, C. P., and Griffiths, K. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions. Eur. J. Cancer, 15: 317–329, 1979.
25. Rochefort, H., and Borgna, J. L. Differences between the activation of the estrogen receptor by oestrogen and by antioestrogen. Nature (Lond.). 292: 257–259, 1981.
26. Rochefort, H., Garcia, M., and Borgna. J. L. Absence of correlation between antiestrogenic activity and binding for the estrogen receptor. Biochem. Biophys. Res. Commun., 88: 351–357, 1979
27. Strobl, J. L., and Uppman. M. E. Prolonged retention of estradiol by human breast cancer cells in tissue culture. Cancer Res., 39: 3319–3327, 1979.
28. Sutherland, R. L., and Foo, M. S. Differential binding of antiestrogens by rat uterine and chick oviduct cytosol. Biochem. Biophys. Res. Commun., 91: 183–191, 1979.
29. Sutherland, R. L., Murphy, L. C., Foo, S. M., Green, M. D., Whybourne, A. M., and Krozowski, Z. S. High affinity antioestrogen binding sites distinct from the oestrogen receptor. Nature (Lond.), 268: 273–275, 1980.
30. Truong, H., and Baulieu, E. E. Interaction of uterus cytosol receptor with estradiol. Equilibrium and kinetic studies. Biochim. Biophys. Acta, 237: 167–172, 1971.
31. Vignon, F., Terqui, M., Westley, B., Derocq, D., and Rochefort, H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology, 106: 1079–1086, 1980.
32. Westley, B., and Rochefort, H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20: 353-362, 1980.
33. Zava, D. T., and McGuire. W. L. Estrogen receptor: unoccupied sites in nuclei of a breast tumor cell line. J. Biol. Chem., 252; 3703–3708, 1977.